{{Rsnum
|rsid=10490823
|Chromosome=3
|position=41082244
|Orientation=minus
|GMAF=0.3416
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 28.3 | 53.1 | 18.6
| HCB | 2.2 | 41.6 | 56.2
| JPT | 2.7 | 45.1 | 52.2
| YRI | 0.0 | 19.7 | 80.3
| ASW | 1.8 | 43.9 | 54.4
| CHB | 2.2 | 41.6 | 56.2
| CHD | 6.4 | 39.4 | 54.1
| GIH | 6.9 | 41.6 | 51.5
| LWK | 0.9 | 14.5 | 84.5
| MEX | 17.2 | 39.7 | 43.1
| MKK | 1.3 | 16.7 | 82.1
| TSI | 27.5 | 44.1 | 28.4
| HapMapRevision=28
}}
{{PMID Auto GWAS
|PMID=19079262
|Trait=Bone mineral density (hip)
|Title=New sequence variants associated with bone mineral density
|RiskAllele=G
|Pval=0.000009
|OR=0.06
|ORtxt=[0.03-0.09] SD decrease
}}

{{PharmGKB
|RSID=rs10490823
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19079262; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: New sequence variants associated with bone mineral density. (Initial Sample Size: 6,865 individuals; Replication Sample Size: 8,510 individuals); (Region: 3p22.1; Reported Gene(s): NR; Risk Allele: rs10490823-G); (p-value= 0.000009).This variant is associated with Bone mineral density (hip).
|Drugs=
|Drug Classes=
|Diseases=Bone Diseases; Bone Diseases, Metabolic
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740135
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs10490823
|overall_frequency_n=45
|overall_frequency_d=128
|overall_frequency=0.351562
|n_genomes=31
|n_genomes_annotated=0
|n_haplomes=41
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}